v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (3,891,460) $ (5,807,141)
Adjustments to reconcile net loss to net cash provided by operating activities    
Fair value of vested stock options 675,828 1,962,000
Fair value of vested restricted common stock 994,361 1,063,918
Fair value of common stock issued for services 226,037 384,088
Loss on fair value of common stock issued for settlement of vendor 33,750
Depreciation of capitalized software costs 289,737 323,080
Right of use assets 169,540 155,724
Amortization of intangible assets 1,128,190 1,100,979
Amortization of debt discount 10,430
Accrued interest 1,500 (14,740)
Changes in operating assets and liabilities:    
Accounts receivable 11,951 81,060
Inventories 457,593 2,094,785
Prepaid expenses and other current assets (113,435) (305,661)
Deposits (6,926)
Accounts payable 383,732 (272,281)
Accrued expenses (174,402) (9,528)
Customer deposits 6,458 (94,847)
Deferred revenue (38,666) 30,453
Deferred taxes (257,500) (293,716)
Operating lease liability (172,985) (152,402)
Net cash provided by (used in) operating activities (310,447) 289,951
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash received on acquisition 109,543
Net cash provided by (used in) investing activities 109,543
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from line of credit 79,335,061 61,299,312
Repayment of line of credit (79,498,825) (63,388,495)
Proceeds from note payable 985,000
Repayment of notes payable (6,987) (825,928)
Repayment of notes payable – related party (2,000,000)
Proceeds from sale of common stock, net of expenses, under at-the-market sale agreement 30,593 1,383,702
Proceeds from sale of common stock, net of expenses, under stock purchase agreement 374,500
Proceeds from public offering of common stock 478,000
Proceeds from private placement of common stock 719,999 250,000
Net cash provided by (used in) financing activities 579,841 (1,443,909)
Net increase (decrease) in cash and cash equivalents 269,394 (1,044,415)
Cash and cash equivalents beginning of period 3,654,944 4,301,842
Cash and cash equivalents end of period 3,924,338 3,257,427
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest paid 233,440 322,289
Taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common shares issued for acquisition 609,000
Common shares issued for trade accounts payable 108,750
Accounts receivable from acquisition 37,499
Deposits from acquisition 2,633
Accounts payable from acquisition 500
Accrued expenses from acquisition $ 13,340